USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Genetic Diagnostics Corp
Address:
160 Community Dr
Great Neck, NY 11021
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
16
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $281,071.00 6
SBIR Phase II $1,065,632.00 3

Award List:

MONOCLONAL ANTIBODIES AND MUNOLOGIC FOR T-2 TOXIN

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$40,000.00
Agency:
USDA
Principal Investigator:
Harvey J. Brandwein
Abstract:
N/a

MONOCLONAL ANTIBODIES AND MUNOLOGIC FOR T-2 TOXIN

Award Year / Program / Phase:
1984 / SBIR / Phase II
Award Amount:
$180,000.00
Agency:
USDA
Principal Investigator:
Harvey J. Brandwein
Abstract:
Trichothecene mycotoxinw by several genera of fungi and cause serious illness and death in animals and humans. these toxins sometimes occur naturally in the environment and aicultural prod. current methods in thericothecenes are highly specialized, laborious proceduresit is proposed to purs the dev-… More

THE CYCLIC NUCLEOTIDES, CAMP AND CGMP ARE IMPORTANT REGULATORY MOLECULES THAT ARE NOW RECOGNIZED AS MEDIATORS IN A VAST NUMBER OF NORMAL AND PATHOLOGICAL PROCESSES.

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Dr. harvey brandwein , DIRECTOR
Abstract:
The cyclic nucleotides, camp and cgmp are important regulatory molecules that are now recognized as mediators in a vast number of normal and pathological processes. such insights have increased the need for generally available technology that will allow the convenient and accurate measurement of the… More

MONOCLONAL ANTIBODIES AND IMMUNOASSAYS FOR CANNABINOIDS

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$51,601.00
Agency:
HHS
Principal Investigator:
Harvey J. Brandwein
Abstract:
N/a

"MONOCLONAL ANTIBODIES AND IMMUNOASSAY FOR E. COLI TOXIN"

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Brandwein
Abstract:
N/a

RECENT STUDIES IN MANY LABORATORIES HAVE DEMONSTRATED THE PRESENCE OF 2 UBIQUITOUS, CLOSELY RELATED ENZYMES, THE CALCIUM-ACTIVATED PROTEASES (CAP I AND II).

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$40,470.00
Agency:
HHS
Principal Investigator:
H. brandwein , PRINCIPAL INVESTIGATOR
Abstract:
Recent studies in many laboratories have demonstrated the presence of 2 ubiquitous, closely related enzymes, the calcium-activated proteases (cap i and ii). in brain, the cap enzymes act on neurofilament proteins and lead to the degradation of these neuronal components. the neurofilament proteins… More

"MONOCLONAL ANTIBODIES AND IMMUNOASSAY FOR E. COLI TOXIN"

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$500,000.00
Agency:
HHS
Principal Investigator:
Brandwein
Abstract:
Recent advances in biochemistry and immunology now make possible new approaches for detection and treatment of infectious diseases. our group is committed to such technological applications, and this phase i proposal is in response to the stated interest of the n.i.a.d.a. in such innovative… More

MONOCLONAL ANTIBODIES AND IMMUNOASSAYS FOR CANNABINOIDS

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$385,632.00
Agency:
HHS
Principal Investigator:
Harvey J. Brandwein
Abstract:
As the use of marihuana has continued to grow, the need for accurate and reliable means of measuring cannabinoid levels has become more urgent. this phase i application outlines our interest in developing such a cannabinoid assay which will be rapid, non-isotopic, and capable of being performed in a… More

NOVEL IMMUNOGENS FOR AMPHETAMINE ENZYME IMMUNOASSAY

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Drug abuse has created a continuing need for a rapid and accurate system for the detection of amphetamines. this sbir proposal addresses the need for a rapid and specific enzyme-linked immunosorbent assay (elisa) for amphetamines which can be performed with only modest laboratory facilities. since… More